News
Imagine treating a genetic disease not by managing symptoms for life, but by correcting the underlying genetic error itself. Inventors at NIH are advancing that vision with a gene editing technology designed to deliver highly precise genetic corrections, opening new possibilities for therapies that
The Food and Drug Administration (FDA)'s Center for Devices and Radiological health (CDRH) recently launched the READI-Home (Reducing Readmissions through Device Innovation for the Home) Innovation Challenge, part of its broader Home as a Health Care Hub initiative, to accelerate development of
Summary As a Program Specialist with the NIH, Office of Technology Transfer you will support the administration and coordination of technology transfer programs by managing program operations, providing administrative and technical support, including timekeeping, travel and training services
A new collaboration between Apertura and the National Institutes of Health (NIH) aims to advance a potential gene therapy for Niemann-Pick Disease Type C1 (NPC1), a rare and often fatal neurodegenerative disorder. Under a newly signed Cooperative Research and Development Agreement (CRADA), NIH and